vaccinations < vaccine < vaccines

Facettes : Author.f AffOrg.f AffPays.f AffRegion.f AffVille.f Teeft.f

List of bibliographic references

Number of relevant bibliographic references: 25.
[0-20] [0 - 20][0 - 25][20-24][20-40]

Ident.	Authors (with country if any)	Title
000130 (2015)		Retracted: Immunological properties reveal the monovalent and bivalent recombinant dengue virus‐like particles as candidate vaccine for dengue
000131 (2015)	Roslyn M. Bill [Royaume-Uni]	Recombinant protein subunit vaccine synthesis in microbes: a role for yeast?
000207 (2015)	Alex M. Nading [Royaume-Uni]	Chimeric globalism: Global health in the shadow of the dengue vaccine
000249 (2014)	J. Hu [États-Unis] ; C. Zhang [États-Unis]	Porcine Reproductive and Respiratory Syndrome Virus Vaccines: Current Status and Strategies to a Universal Vaccine
000564 (2012)	Yongqun He [États-Unis]	Omics‐Based Systems Vaccinology for Vaccine Target Identification
000626 (2012)	Samuel Yeung Shan Wong [Hong Kong] ; Chun Kwok Wong [Hong Kong] ; Frank Wan Kin Chan [Hong Kong] ; Paul K. S. Chan [Hong Kong] ; Karry Ngai [Hong Kong] ; Stewart Mercer [Royaume-Uni] ; Jean Woo [Hong Kong]	Chronic psychosocial stress: does it modulate immunity to the influenza vaccine in Hong Kong Chinese elderly caregivers?
000687 (2011)	Emily M. Plummer [États-Unis] ; Marianne Manchester [États-Unis]	Viral nanoparticles and virus‐like particles: platforms for contemporary vaccine design
000799 (2011)	Shirin Tarahomjoo [Iran]	Development of Vaccine Delivery Vehicles Based on Lactic Acid Bacteria
000C56 (2009)	Lawrence O. Gostin	Swine Flu Vaccine: What Is Fair?
000E06 (2009)	W. P. Poh [Singapour] ; T. Narasaraju [Singapour] ; N. A. Pereira [Singapour] ; F. Zhong [Singapour] ; M. C. Phoon [Singapour] ; P. A. Macary [Singapour] ; S. H. Wong [Singapour] ; J. Lu [Singapour] ; D. R. Koh [Singapour] ; Vincent T. K. Chow [Singapour]	Characterization of cytotoxic T‐lymphocyte epitopes and immune responses to SARS coronavirus spike DNA vaccine expressing the RGD‐integrin‐binding motif
000E32 (2009)	M. T. Heise [États-Unis] ; A. Whitmore [États-Unis] ; J. Thompson [États-Unis] ; M. Parsons [États-Unis] ; A. A. Grobbelaar ; A. Kemp ; J. T. Paweska ; K. Madric [États-Unis] ; L. J. White [États-Unis] ; R. Swanepoel ; F. J. Burt	An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus
000F23 (2008)	Melanie Albrecht [Allemagne] ; Yasemin Suezer [Allemagne] ; Caroline Staib [Allemagne] ; Gerd Sutter [Allemagne] ; Stefan Vieths [Allemagne] ; Gerald Reese [Allemagne]	Vaccination with a Modified Vaccinia Virus Ankara‐based vaccine protects mice from allergic sensitization
000F26 (2008)	J. J. Joensuu [Finlande, Canada] ; V. Niklander-Teeri [Finlande] ; J. E. Brandle [Canada]	Transgenic plants for animal health: plant-made vaccine antigens for animal infectious disease control
000F84 (2008)	S. M. Mniszewski [États-Unis] ; S. Y. Del Valle [États-Unis] ; P. D. Stroud [États-Unis] ; J. M. Riese [États-Unis] ; S. J. Sydoriak [États-Unis]	Pandemic simulation of antivirals + school closures: buying time until strain-specific vaccine is available
001330 (2007)	A. Pratelli [Italie]	High‐cell‐passage canine coronavirus vaccine providing sterilising immunity
001618 (2006)	David K. Clarke [États-Unis] ; David Cooper [États-Unis] ; Michael A. Egan [États-Unis] ; R. Michael Hendry [États-Unis] ; Christopher L. Parks [États-Unis] ; Stephen A. Udem [États-Unis]	Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector
001624 (2006)	Takeshi Ichinohe [Japon] ; Izumi Watanabe [Japon] ; Eriko Tao [Japon] ; Satoshi Ito [Japon] ; Akira Kawaguchi [Japon] ; Shin-Ichi Tamura [Japon] ; Hidehiro Takahashi [Japon] ; Hirofumi Sawa [Japon] ; Masami Moriyama [Japon] ; Joe Chiba [Japon] ; Katsuhiro Komase [Japon] ; Yujiro Suzuki [Japon] ; Takeshi Kurata [Japon] ; Tetsutaro Sata [Japon] ; Hideki Hasegawa [Japon]	Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant
001D89 (2004)	C. Sylvester-Hvid [Danemark] ; M. Nielsen [Danemark] ; K. Lamberth [Danemark] ; G. R Der [Danemark] ; S. Justesen [Danemark] ; C. Lundegaard [Danemark] ; P. Worning [Danemark] ; H. Thomadsen [Danemark] ; O. Lund [Danemark] ; S. Brunak [Danemark] ; S. Buus [Danemark]	SARS CTL vaccine candidates; HLA supertype‐, genome‐wide scanning and biochemical validation
001F21 (2004)	K. S. Jayaraman	India targets local HIV strain in test of AIDS vaccine
002081 (2004)	Naomi Takasuka ; Hideki Fujii ; Yoshimasa Takahashi ; Masataka Kasai ; Shigeru Morikawa ; Shigeyuki Itamura ; Koji Ishii ; Masahiro Sakaguchi ; Kazuo Ohnishi ; Masamichi Ohshima ; Shu-Ichi Hashimoto ; Takato Odagiri ; Masato Tashiro ; Hiroshi Yoshikura [Japon] ; Toshitada Takemori ; Yasuko Tsunetsugu-Yokota	A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice
002091 (2004)	Zhi-Yong Yang [États-Unis] ; Wing-Pui Kong [États-Unis] ; Yue Huang [États-Unis] ; Anjeanette Roberts [États-Unis] ; Brian R. Murphy [États-Unis] ; Kanta Subbarao [États-Unis] ; Gary J. Nabel [États-Unis]	A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Istex/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "vaccine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i  \
                -Sk "vaccine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Title.i
   |clé=    vaccine
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021